Barclays’s Zevra Therapeutics ZVRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $919K | Sell |
104,351
-330,339
| -76% | -$2.91M | ﹤0.01% | 2714 |
|
2025
Q1 | $3.26M | Buy |
434,690
+145,002
| +50% | +$1.09M | ﹤0.01% | 1711 |
|
2024
Q4 | $2.42M | Buy |
289,688
+232,089
| +403% | +$1.94M | ﹤0.01% | 2080 |
|
2024
Q3 | $399K | Buy |
57,599
+42,926
| +293% | +$297K | ﹤0.01% | 3115 |
|
2024
Q2 | $72K | Sell |
14,673
-10,933
| -43% | -$53.6K | ﹤0.01% | 3528 |
|
2024
Q1 | $148K | Sell |
25,606
-24,391
| -49% | -$141K | ﹤0.01% | 3482 |
|
2023
Q4 | $327K | Buy |
49,997
+44,032
| +738% | +$288K | ﹤0.01% | 3262 |
|
2023
Q3 | $29K | Sell |
5,965
-971
| -14% | -$4.72K | ﹤0.01% | 3801 |
|
2023
Q2 | $35K | Buy |
6,936
+6,827
| +6,263% | +$34.5K | ﹤0.01% | 3826 |
|
2023
Q1 | $1K | Sell |
109
-244
| -69% | -$2.24K | ﹤0.01% | 4269 |
|
2022
Q4 | $2K | Sell |
353
-1,304
| -79% | -$7.39K | ﹤0.01% | 4300 |
|
2022
Q3 | $10K | Buy |
+1,657
| New | +$10K | ﹤0.01% | 4192 |
|
2019
Q3 | – | Sell |
-6
| Closed | – | – | 4454 |
|
2019
Q2 | $0 | Sell |
6
-281
| -98% | – | ﹤0.01% | 4465 |
|
2019
Q1 | $0 | Buy |
287
+186
| +184% | – | ﹤0.01% | 4438 |
|
2018
Q4 | $0 | Hold |
101
| – | – | ﹤0.01% | 4436 |
|
2018
Q3 | $0 | Hold |
101
| – | – | ﹤0.01% | 4504 |
|
2018
Q2 | $1K | Sell |
101
-1
| -1% | -$10 | ﹤0.01% | 4142 |
|
2018
Q1 | $1K | Buy |
102
+1
| +1% | +$10 | ﹤0.01% | 4146 |
|
2017
Q4 | $0 | Hold |
101
| – | – | ﹤0.01% | 4218 |
|
2017
Q3 | $0 | Sell |
101
-300
| -75% | – | ﹤0.01% | 4158 |
|
2017
Q2 | $1K | Buy |
401
+300
| +297% | +$748 | ﹤0.01% | 3793 |
|
2017
Q1 | $0 | Sell |
101
-2,600
| -96% | – | ﹤0.01% | 4175 |
|
2016
Q4 | $8K | Buy |
2,701
+2,632
| +3,814% | +$7.8K | ﹤0.01% | 3333 |
|
2016
Q3 | $0 | Sell |
69
-111
| -62% | – | ﹤0.01% | 4081 |
|
2016
Q2 | $1K | Buy |
180
+100
| +125% | +$556 | ﹤0.01% | 3480 |
|
2016
Q1 | $1K | Sell |
80
-178
| -69% | -$2.23K | ﹤0.01% | 3343 |
|
2015
Q4 | $5K | Sell |
258
-1,242
| -83% | -$24.1K | ﹤0.01% | 2918 |
|
2015
Q3 | $29K | Buy |
+1,500
| New | +$29K | ﹤0.01% | 2752 |
|